Sp1161
IS MEDICAL TREATMENT FOR HRS-AKI POTENTIALLY HARMFUL FOR PATIENTS AS IT REDUCES THEIR PRIORITY FOR LIVER TRANSPLANTATION? NO
Date
May 21, 2024
Presenter
Tracks
Related Products
HEPTORENAL SYNDROME: A NEW DRUG FOR AN OLD DISEASE
SOCIETY: AASLD
ALBUMIN USE AND AKI ARE INDEPENDENTLY ASSOCIATED WITH RESPIRATORY DISTRESS DEVELOPMENT IN A MULTI-CENTER COHORT OF INPATIENTS WITH CIRRHOSIS
BACKGROUND: Hepatorenal syndrome (HRS) with rapidly deteriorating kidney function can be effectively reversed when treated with terlipressin, the US FDA-approved vasopressin analogue…
